Swipe om te navigeren naar een ander artikel
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
To investigate the association between potentially inappropriate medication (PIM)/potential prescribing omission (PPO) and the health-related quality of life (HRQoL) among community-dwelling hospitalized elderly patients.
This is a cross-sectional study that took place in a Malaysian tertiary hospital. Patients ≥ 65 years old with at least one medication on admission were recruited. The patients’ prehospitalization medications were reviewed to identify PIMs/PPOs using version 2 of the STOPP/START criteria. HRQoL was assessed using the EuroQol-5 dimensions (EQ-5D) and EuroQol-visual analog scale (EQ-VAS). The association between the presence of PIM/PPO and the patients’ HRQoL was analyzed using Chi-square and Mann–Whitney U tests. Multiple linear regression models were applied to determine the effect of exposure to PIM/PPO on the patients’ HRQoL, adjusting for confounders.
Out of 517 patients who fulfilled the inclusion criteria, 502 patients (97%) accepted to be involved in the study and completed the HRQoL questionnaire. The mean (SD) age was 72.4 (5.9) years. 393 (78.3%) of the patients had problems in at least one EQ-5D dimension with pain/discomfort problem being the most reported complaint. The mean (SD) values of the EQ-5D index and the EQ-VAS were 0.734 (0.214) and 59.6 (14.2), respectively, which are lower than those seen in the general Malaysian population. PIM and PPO were found in 28.5% and 45.6% of the patients, respectively. No significant differences were found in the EQ-5D dimensions, EQ-5D index and EQ-VAS between patients who had PIM/PPO and those who did not. Age, sex, and comorbidities were significantly associated with the patients’ HRQoL.
PIM and PPO are not uncommon among hospitalized elderly patients; however, it does not significantly affect their HRQoL as measured by the EQ-5D-3L instrument.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Kaplan, R. M. (2003). The significance of quality of life in health care. In Quality of life research (Vol. 12, pp. 3–16). Dordrecht: Kluwer Academic Publishers. https://doi.org/10.1023/A:1023547632545.
OʼConnor, M. N., Gallagher, P., & OʼMahony, D. (2012). Inappropriate prescribing: Criteria, detection and prevention. Drugs & Aging, 29(6), 437–452. https://doi.org/10.2165/11632610-000000000-00000. CrossRef
Hamilton, H., Gallagher, P., Ryan, C., Byrne, S., & O’Mahony, D. (2011). Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Archives of Internal Medicine, 171(11), 1013–1019. https://doi.org/10.1001/archinternmed.2011.215. CrossRef
van der Stelt, C. A. K., Windsant-van den Tweel, A. M. A., Egberts, A. C. G., Van den Bemt, P. M. L. A., Leendertse, A. J., Hermens, W. A. J. J., Derijks, H. J. (2016). The association between potentially inappropriate prescribing and medication-related hospital admissions in older patients: A nested case control study. Drug Safety, 39(1), 79–87. https://doi.org/10.1007/s40264-015-0361-1. CrossRef
Wallace, E., McDowell, R., Bennett, K., Fahey, T., & Smith, S. M. (2017). Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: A prospective cohort study. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 72(2), 271–277. https://doi.org/10.1093/gerona/glw140. CrossRef
Meid, A. D., Quinzler, R., Groll, A., Wild, B., Saum, K. U., Schöttker, B., Haefeli, W. E. (2016). Longitudinal evaluation of medication underuse in older outpatients and its association with quality of life. European Journal of Clinical Pharmacology, 72(7), 877–885. https://doi.org/10.1007/s00228-016-2047-8. CrossRef
Moriarty, F., Bennett, K., Cahir, C., Kenny, R. A., & Fahey, T. (2016). Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community-dwelling older people: a prospective cohort study. British Journal of Clinical Pharmacology, 82, 849–857. https://doi.org/10.1111/bcp.12995. CrossRef
Al Aqqad, S. M. H., Chen, L. L., Shafie, A. A., Hassali, M. A., & Tangiisuran, B. (2014). The use of potentially inappropriate medications and changes in quality of life among older nursing home residents. Clinical Interventions in Aging, 9, 201–207. https://doi.org/10.2147/CIA.S52356.
Lim, L. M., McStea, M., Chung, W. W., Azmi, N. N., Aziz, S. A. A., Alwi, S., Rajasuriar, R. (2017). Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multiethnic Malaysia. PLoS ONE, 12(3), 1–18. https://doi.org/10.1371/journal.pone.0173466.
Najjar, M. F., AbdulRazzaq, H. A., Altaie, A. H., Kassab, Y. W., Hassan, Y., & Abd Aziz, N., (2013). Assessment of potentially inappropriate medications and risk of drug-drug interactions among geriatric inpatients in Penang Hospital. International Journal of Clinical Pharmacy (Vol, 35, 911–912.
Population distribution and basic demographic characteristic report. (2011). Retrieved from https://www.dosm.gov.my/v1/index.php?r=column/ctheme&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09&bul_id=MDMxdHZjWTk1SjFzTzNkRXYzcVZjdz09.
Naing, L., Winn, T., & Rusli, B. N. (2006). Practical issues in calculating the sample size for prevalence studies. Archives of Orofacial Sciences, 1, 9–14. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.504.2129&rep=rep1&type=pdf.
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., Le Couteur, D. G. (2012). Polypharmacy cutoff and outcomes: Five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. Journal of Clinical Epidemiology, 65(9), 989–995. https://doi.org/10.1016/j.jclinepi.2012.02.018. CrossRef
Md Yusof, F. A., Goh, A., & Azmi, S. (2012). Estimating an EQ-5D value set for malaysia using time trade-off and visual analogue scale methods. Value in Health, 15(1 SUPPL.), S85–S90. https://doi.org/10.1016/j.jval.2011.11.024. CrossRef
Wolfs, C. A. G., Dirksen, C. D., Kessels, A., Willems, D. C. M., Verhey, F. R. J., & Severens, J. L. (2007). Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments. Health and Quality of Life Outcomes, 5(33). https://doi.org/10.1186/1477-7525-5-33.
Clemens, S., Begum, N., Harper, C., Whitty, J. A., & Scuffham, P. A. (2014). A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 23(8), 2375–2381. https://doi.org/10.1007/s11136-014-0676-x. CrossRef
König, H. H., Heider, D., Lehnert, T., Riedel-Heller, S. G., Angermeyer, M. C., Matschinger, H., Alonso, J. (2010). Health status of the advanced elderly in six european countries: Results from a representative survey using EQ-5D and SF-12. Health and Quality of Life Outcomes, 8(1), 143. https://doi.org/10.1186/1477-7525-8-143. CrossRef
Perneger, T. V., Combescure, C., & Courvoisier, D. S. (2010). General population reference values for the french version of the euroqol EQ-5D health utility instrument. Value in Health, 13(5), 631–635. https://doi.org/10.1111/j.1524-4733.2010.00727.x. CrossRef
Fu, A. Z., Liu, G. G., & Christensen, D. B. (2004). Inappropriate medication use and health outcomes in the elderly. Journal of the American Geriatrics Society, 52(11), 1934–1939. https://doi.org/10.1111/j.1532-5415.2004.52522.x. CrossRef
- Does inappropriate prescribing affect elderly patients’ quality of life? A study from a Malaysian tertiary hospital
Muhammad Eid Akkawi
Mohamad Haniki Nik Mohamed
Mohd Aznan Md Aris
- Springer International Publishing